SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-180280
Filing Date
2018-05-31
Accepted
2018-05-31 16:05:57
Documents
4
Period of Report
2018-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d590049d8k.htm 8-K 19330
2 EX-10.1 d590049dex101.htm EX-10.1 714306
3 GRAPHIC g590049dsp059.jpg GRAPHIC 178757
4 GRAPHIC g590049dsp060.jpg GRAPHIC 148921
  Complete submission text file 0001193125-18-180280.txt   1186460
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 18871608
SIC: 2834 Pharmaceutical Preparations